What Bimeda does

Bimeda Holdings Limited is an Irish-headquartered (Dublin) veterinary pharmaceutical company founded in 1960 and owned by the Tierney family since 1973. The company develops, manufactures, and distributes veterinary medicines, vaccines, nutritionals, and diagnostic services across livestock (cattle, poultry, sheep), companion animals (dogs, cats), equine, and aquaculture species, serving customers in over 80 countries through direct sales teams, exclusive distribution partnerships, and 10+ local country websites. Product lines span parasite management, infectious disease control, vaccines, reproductive health, joint health, sedatives, nutritional supplements, and aquaculture services through its AquaTactics division.

Bimeda operates nine manufacturing facilities across the United States (Le Sueur, San Angelo, Seattle), Canada (Cambridge), the United Kingdom (Denbigh), Ireland (Dublin), Brazil (Monte Mor), Argentina (Florida Oeste), and China (Shijiazhuang), plus eight R&D laboratories, with regulatory regimes covering FDA, USDA, EU EMA, MAPA, Senasa, and China Human Drug GMP. The company holds over 1,600 marketing authorisations globally and pioneered both the first intramammary teat sealant (1970s) and the world's only soluble glass multiple trace element bolus technology (Telsol). Diagnostic services are delivered through ISO 17025-accredited Iodolab (France), Bimeda Biologicals (San Angelo, Texas; St. Paul, Minnesota), and the FDA-inspected Rainbowlabs joint venture in China.

Revenue is generated predominantly through one-time product sales of pharmaceuticals and vaccines (pharmaceutical and nutritional products) plus ancillary revenue from diagnostic and aquaculture professional services. Pricing is not publicly disclosed; products are sold via direct enterprise sales to veterinarians and animal producers, via channel partners (e.g., Duggan Veterinary Supplies for UK/Ireland equine), and via regional e-commerce storefronts. Recent strategic activity (2022-2026) includes the Afrivet acquisition for African leadership, the €25M+ Shijiazhuang sterile injectable facility, USDA approval for autogenous fish vaccines in 2025, multi-phase Brazil expansion in 2025, and the April 2026 acquisition of Dechra's Pomona California manufacturing assets — all consistent with continued geographic and vertical expansion financed through family-owned capital rather than external investors.

Name

Bimeda

Legal name

Bimeda Holdings Limited

Website

https://bimeda.com

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Bimeda is a privately-held, Ireland-headquartered veterinary pharmaceutical manufacturer founded in 1960 that develops and sells medicines, vaccines, nutritionals, and diagnostic services for livestock, companion animals, equine, and aquaculture species in over 80 countries through nine manufacturing facilities.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Animal Food Manufacturing (3111)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

akta.pro secondary industries

Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns) (HLAMAIAG), Veterinary Vaccines (Biologics) (HLAMAEAL)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Veterinary vaccines
• Livestock pharmaceuticals
• Aquaculture health services

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices13 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Veterinary Pharmaceuticals Sales: Bimeda develops, manufactures, markets, and distributes veterinary medicines, vaccines, nutritionals and animal health products globally. Revenue is generated through direct product sales to veterinarians, animal producers, and through distribution partners.
2. Diagnostic Services: Bimeda offers diagnostic and analytical services through diagnostic laboratories in France and the USA, providing testing and analysis services to pharmaceutical companies and animal health professionals.
3. Aquaculture Services: Bimeda's aquaculture division AquaTactics provides fish health services including veterinary consultation, pathology, vaccination protocol design, and fish health products to aquaculture operations across the USA.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Bimeda develops, manufactures, markets, and distributes veterinary pharmaceuticals, vaccines, nutritional supplements, and animal health products across species including livestock, poultry, equine, companion animals, and aquaculture. The company operates 9 manufacturing facilities and 8 R&D facilities across 4 continents, and sells its products in over 80 countries through direct sales teams and distribution partners. It also offers diagnostic laboratory services and aquaculture-specific veterinary consultation and custom vaccine design through its AquaTactics division.

Product overview

Bimeda Animal Health Ltd. is a global veterinary pharmaceutical and animal health company that develops, manufactures, markets, and distributes an extensive range of veterinary medicines, vaccines, nutritionals, and animal health products sold in over 80 countries worldwide. The company's product portfolio includes parasite management products (Bimectin Oral Paste, Embotape, Parvexon Plus), equine health products (Cronyxin Oral Paste, Gastrobim/Bimeprazol), anti-infectives (SpectoGard Sterile Solution), nutritional supplements (BOVitalize), diagnostic tools (ImmunIGY Bovine IgG), and aquaculture services (AquaTactics). Bimeda operates across eight focus areas: parasite management, nutrition, pain management, infectious disease management, vaccines and preventative health, reproductive health, joint health, sedatives, and aquaculture. The company offers products for livestock, poultry, horses, companion animals, and aquatic animals. Services include diagnostic laboratories in France and the USA (Iodolab, Bimeda Biologicals, Rainbowlabs), aquaculture services through AquaTactics, and sustainability initiatives.

Differentiator

Problem solved

Functional benefit

Brands

• Bimectin: Oral paste for equine/deworming
• Macrosyn
• Cidental
• Coseicure
• Doracide
• Stimulator
• Parvexon Plus Injection
• Polyglycan
• Cronyxin
• BOVitalize
• SpectoGard (spectinomycin sulfate)
• ImmunIGY Bovine IgG
• Gastrobim / Bimeprazol
• AquaTactics
• Iodolab
• Rainbow Labs
• Embotape
• ImmunIGY

Products and services

• Bimectin Oral Paste Oral paste deworming product for parasite management in horses.
• Embotape Oral Paste Oral paste deworming product for parasite management in horses.
• Cronyxin Oral Paste Oral paste formulation for animal health management in horses.
• Gastrobim / Bimeprazol (Omeprazole Oral Paste) Omeprazole oral paste for gastric health management in horses. Distributed as Gastrobim in Ireland and Bimeprazol in the UK.
• SpectoGard (spectinomycin sulfate) Sterile Solution FDA-approved aminocyclitol antibiotic sterile injectable solution for cattle, for treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. Bioequivalent to Adspec (Zoetis).
• BOVitalize Oral vitamin and mineral supplement for beef and dairy cows, bulls and ruminating calves. Contains selenium, copper, zinc, vitamin A and vitamin E. Administered as a single oral dose of 5 mL per 220 pound of body weight. Designed to support cattle productivity during stressful events.
• ImmunIGY Bovine IgG Novel blood test using lateral flow device that directly measures calf IgG levels in just 10 minutes, enabling early detection of Failure of Passive Transfer. Winner of the Royal Dairy Innovation Award 2024.
• Hemosilate Bimeda product for use in dogs that reduces the severity and duration of bleeding by 50%, intended for emergency situations.
• Polyglycan Veterinary product for joint health management in animals.
• Parvexon Plus Injection Injection product for parasite management in animals.
• Coseicure Animal health product in the Bimeda portfolio.
• Cidental Animal health product in the Bimeda portfolio.
• Doracide Animal health product in the Bimeda portfolio.
• Stimulator Animal health product in the Bimeda portfolio.
• Macrosyn Veterinary pharmaceutical product in the Bimeda portfolio.
• AquaTactics Autogenous Fish Vaccines USDA-approved custom autogenous fish vaccines produced at the Bimeda Biologicals facility in San Angelo, Texas, tailored to specific disease challenges in fish farms across all 50 U.S. states.
• Diagnostics Services Diagnostic and analytical laboratory services provided through Iodolab in France (NF EN ISO 17025:2017 accredited for trace elements, vitamins, and minerals testing), Bimeda Biologicals in San Angelo, Texas (microorganism analysis, serotyping, antibiotic sensitivity, virus/bacteria identification), Bimeda Biologicals in St. Paul, Minnesota (high throughput sequencing, Mycoplasma PCR, PRRSV PCR), and the Rainbowlabs joint venture in Shijiazhuang, China (FDA, Health Canada, ISO, CNAS accredited raw materials testing).
• AquaTactics Fish Health Services Aquaculture division based in Seattle, Washington (USA) providing veterinary consultation, pathology services, fish health education, aqua-business coaching, regulatory approval consultation, and custom prescription vaccination design for fish farming operations.

Quantifiable outcome

• ImmunIGY Bovine IgG test provides definitive direct results for calf IgG levels in 10 minutes, enabling early detection of Failure of Passive Transfer
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• NSPCA (Ireland)minorOthers · 13 February 2026Bimeda Ireland announced 2026 Corporate Partnership with National Society for the Prevention of Cruelty to Animals (NSPCA) in Ireland, strengthening long-standing commitment to supporting animal welfare and contributing positively to communities where they operate.
• USDAcoreOthers · 11 March 2025AquaTactics, Bimeda's Washington-based aquaculture division, received USDA approval to enter the autogenous fish vaccine sector. Autogenous fish vaccine production and wet-lab safety testing takes place at Bimeda's vaccine facility Bimeda Biologicals in San Angelo, Texas, enabling production of custom vaccines tailored to specific disease challenges in fish farms across all 50 US states.
• Access VetMedminorOthers · 7 February 2025Bimeda is a proud member of Access VetMed, the voice of Europe's generic veterinary medicines industry. Access VetMed published 2024 European Market Study on Generic and Value-Added Veterinary Medicines showing members hold 52% of all veterinary generic authorizations in Europe.
• Duggan Veterinary SuppliescoreChannel Partner/ Reseller/ Distributor · 1 December 2024Bimeda Ireland and Bimeda UK announced exclusive equine product distribution partnership with Duggan Veterinary Supplies (DVS) effective January 1, 2025. Bimeda's equine-specific range including Bimectin Oral Paste, Embotape Oral Paste, Cronyxin Oral Paste, and Gastrobim/Bimeprazol oral paste will be distributed exclusively by DVS in UK and Ireland. All new Bimeda equine product introductions will also be distributed by DVS.
• Moredun Research InstitutecoreStrategic or Co-development Partner · 29 January 2024Bimeda partnered with Moredun Research Institute and University of Stirling's Institute of Aquaculture to develop a novel oral vaccine for salmon lice. Bimeda contributed £150k to the £1.5M project led by Dr Kim Thompson at Moredun. The project utilizes reverse vaccinology and AI via EpitoPredikt platform from EpitogenX to develop an oral vaccine for Atlantic salmon.
• University of Stirling Institute of AquaculturecoreStrategic or Co-development Partner · 29 January 2024Collaboration on salmon louse vaccine development. Dr Sean Monaghan will conduct and run vaccine trials and assess molecular aspects of the parasite at infectious life stages that could be exploited for vaccination. Trials will take place at the University's Marine Environmental Research Laboratory (MERL).
• Vertebrate Antibodies LtdminorStrategic or Co-development Partner · 29 January 2024Collaboration partner in salmon louse vaccine development project with Industrial Award Partnership contribution from Bimeda.
• University College DublincoreStrategic or Co-development Partner · 25 October 2023Bimeda made substantial philanthropic donation to UCD Foundation to establish UCD Bimeda Herd Health Hub and AgTechUCD Innovation Centre at UCD Lyons Farm. The facility serves as a national facility for dairy herd health education, research, and consultancy, supporting state-of-the-art training for veterinary students. Funding also provided by Enterprise Ireland through Regional Enterprise Development Fund.
• Shijiazhuang Rainbowlabs Pharmaceutical Technology Co. LtdcoreStrategic or Co-development Partner · 21 October 2022Joint venture with Rainbowlabs providing high quality laboratory testing and services to pharmaceutical companies throughout the world. Rainbowlabs has received highest accreditation from U.S. FDA, Health Canada, ISO and CNAS. The facility provides complete release testing, R&D, and cGMP auditing capabilities.

Scale indicators7 records

Recent moves10 records

Expansion highlights6 records

Market position

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bimeda